Medley, Inc. (MDLYF)
OTCMKTS · Delayed Price · Currency is USD
16.09
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Medley Revenue
Medley had revenue of 9.07B JPY in the quarter ending September 30, 2025, with 30.78% growth. This brings the company's revenue in the last twelve months to 35.20B, up 31.95% year-over-year. In the year 2024, Medley had annual revenue of 29.30B with 42.71% growth.
Revenue (ttm)
35.20B JPY
Revenue Growth
+31.95%
P/S Ratio
1.99
Revenue / Employee
23.67M JPY
Employees
1,487
Market Cap
473.27M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 29.30B | 8.77B | 42.71% |
| Dec 31, 2023 | 20.53B | 6.35B | 44.74% |
| Dec 31, 2022 | 14.19B | 3.32B | 30.58% |
| Dec 31, 2021 | 10.86B | 4.03B | 59.05% |
| Dec 31, 2020 | 6.83B | 2.07B | 43.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Vaso Corporation | 89.11M |
| Veri Medtech Holdings | 11.89M |
| Pharma-Bio Serv | 9.00M |
| CareView Communications | 8.82M |
| DATATRAK International | 6.50M |
| BioRegenx | 1.93M |